859 followers
Congratulations to @JianGuoZhou3 on his public disclosure, “329 Early blood cell count test (BCT) for survival prediction for non-small cell lung cancer patients treated with atezolizumab: integrated analysis of 4 multicenter clinical trials.” https://t.co